Prescription ·Strong evidence ·Reviewed May 2026
Captopril is a short-acting, orally active angiotensin-converting enzyme (ACE) inhibitor used to treat hypertension, heart failure, left ventricular dysfunction after myocardial infarction, and diabetic nephropathy. It was the first ACE inhibitor brought to market and contains a sulfhydryl group that distinguishes it from later agents. Because of its short half-life it is typically dosed two to three times daily, and it is taken on an empty stomach since food reduces its absorption.
The bottom line
Evidence rating strong. Most-documented uses: hypertension, heart failure with reduced ejection fraction, left ventricular dysfunction after myocardial infarction. 3 sources indexed (1998–2012), with 7 interaction records on file.
Core mechanism
Captopril competitively inhibits angiotensin-converting enzyme (ACE, kininase II), preventing the conversion of angiotensin I to the potent vasoconstrictor angiotensin II. The resulting fall in angiotensin II reduces vasoconstriction and lowers aldosterone secretion, decreasing sodium and water retention while promoting potassium retention. Reduced ACE activity also slows the breakdown of bradykinin, contributing to vasodilation and to the characteristic dry cough. The net effect is lowered systemic vascular resistance and blood pressure, with reduced cardiac afterload that benefits patients with heart failure.2,3
Food reduces the absorption of captopril by roughly 30 to 40 percent, so it should be taken at least one hour before meals to ensure consistent bioavailability.
Nutrients this medication can lower over time, and what to replace.
Captopril contains a sulfhydryl (thiol) group that chelates zinc, forming a captopril-zinc complex that increases urinary zinc excretion. Chronic ACE inhibition with sulfhydryl-containing agents can lower plasma and cellular zinc concentrations, and zinc loss has been implicated in taste disturbances (dysgeusia) reported with the drug.
Potassium supplements or potassium-containing salt substitutes can cause hyperkalemia with Captopril.
Recommendation: Avoid unsupervised potassium supplementation; check potassium and kidney function after initiation, dose changes, or illness.
Magnesium Glycinate may add to the blood-pressure-lowering effect of Captopril.
Recommendation: Monitor blood pressure and dizziness, especially during dose changes; stop the supplement and seek advice if syncope, falls, or symptomatic hypotension occurs.
L-Citrulline may add to the blood-pressure-lowering effect of Captopril.
Recommendation: Monitor blood pressure and dizziness, especially during dose changes; stop the supplement and seek advice if syncope, falls, or symptomatic hypotension occurs.
Captopril, like other ACE inhibitors, reduces aldosterone secretion and promotes renal potassium retention, raising serum potassium. Adding a potassium supplement (or potassium-containing salt substitutes) can produce additive hyperkalemia, which may cause muscle weakness, paresthesias, and potentially dangerous cardiac arrhythmias. Risk is greatest in patients with renal impairment, diabetes, heart failure, the elderly, and those also taking potassium-sparing diuretics.
Recommendation: Avoid routine potassium supplements and potassium-based salt substitutes unless specifically prescribed and monitored. If potassium is clinically necessary, use under medical supervision with periodic serum potassium and renal function checks. Report symptoms such as muscle weakness, numbness, or palpitations.
Oral iron salts can react with captopril, which contains a free sulfhydryl (thiol) group, forming a complex that reduces captopril absorption and may diminish its blood-pressure-lowering effect. Co-administration has been shown to lower captopril bioavailability.
Recommendation: Separate doses. Take captopril at least 2 hours before or 2 hours after oral iron supplements to avoid reduced absorption of the ACE inhibitor.
The sulfhydryl group of captopril chelates zinc and increases urinary zinc excretion, and long-term ACE inhibitor therapy has been associated with reduced zinc status in some patients. Low zinc has been linked to taste disturbances, a recognized captopril side effect. Conversely, when supplementing, zinc and captopril taken together may chelate in the gut and modestly reduce absorption of each.
Recommendation: No supplement is required for most patients. If taste disturbance or signs of zinc deficiency develop during long-term captopril therapy, discuss zinc status with a clinician. If supplementing zinc, separating it from captopril by about 2 hours may limit gut chelation.
Garlic extract has modest blood-pressure-lowering properties and may add to the antihypertensive effect of captopril. While this can be beneficial, the additive effect could occasionally cause blood pressure to fall lower than intended, particularly when starting or up-titrating either agent.
Recommendation: The combination is generally acceptable and may be additive in a helpful way, but monitor blood pressure when adding garlic extract to captopril, especially at higher garlic doses. Report symptoms of low blood pressure such as dizziness, lightheadedness, or fainting.
Numbered references. Citations throughout the page link here.
Reduced aldosterone secretion from ACE inhibition impairs renal potassium excretion, and combining these drugs with potassium supplements or potassium-sparing agents markedly raises hyperkalemia risk.
Captopril is indicated for hypertension, congestive heart failure, left ventricular dysfunction after myocardial infarction, and diabetic nephropathy, with food reducing absorption by 30 to 40 percent.
Captopril, which contains a sulfhydryl group that chelates zinc, has been linked to increased urinary zinc loss and to dysgeusia, a recognized side effect of the drug.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
